Carcinoembryonic Antigen (CEA) market Research Report by Application (breast cancer, prostate cancer, pancreatic cancer, lung cancer, Thyroid cancer, liver cancer)- Forecast to 2027
About Carcinoembryonic Antigen (CEA):
CEA remains for Carcinoembryonic antigen. CEA is a type of glycoprotein particle that is produced by cells of the gastrointestinal tract amid embryonic improvement. It is delivered in little amount after birth. The level of CEA in the circulatory system is along these lines moderately low unless certain sicknesses – including certain types of disease – are available. Carcinoembryonic antigen (CEA) depicts a plan of very related glycoproteins required in cell connection. CEA is ordinarily present exactly at low levels in the blood of sound grown-ups. Regardless, If the serum levels are raised in some kind of disease, which infers that it can be utilized as a tumor producer in clinical tests. Serum levels can moreover be brought up in overpowering smokers. CEA are glycosyl phosphatidyl inositol (GPI) cell surface tied down glycoproteins whose particular sialofucosylated glycoforms fill in as practical colon carcinoma L-selectin and E-selectin ligands, which might be essential to the metastatic spread of colon carcinoma cells. Immunologically they are depicted as people from the CD66 bunch of separation
An ordinary level of CEA is equivalent to or under 3 nanograms for each milliliter (ng/mL). Most sound grown-ups have levels underneath this sum. CEA levels will for the most part come back to ordinary in the vicinity of one and four months after malignancy has been effectively expelled from a patients framework.
The common reasons other than cancer for the growth of Carcinoembryonic antigen CEA are
- Cirrhosis of the liver
- Inflammatory bowel disease
- Heavy smoking
Sample Report Available at https://www.marketresearchfuture.com/sample_request/772
Carcinoembryonic Antigen (CEA) test Application
A CEA test is most useful if you’ve been diagnosed with a type of cancer, which is known to produce CEA. Not all types of cancers produce CEA. Increased levels of CEA may be found in the following cancers:
- breast cancer
- lung cancer
- prostate cancer
- liver cancer
- colorectal cancer
- pancreatic cancer
- Thyroid cancer
Major Market Players:
Roche Diagnostics, Quest Diagnostics, Correlogic Systems, Inc., GenWay Biotech Inc.
Market growth driver:
With the diagnosis of different types of cancers in the globe, Carcinoembryonic Antigen (CEA) test helps the doctor to diagnose and find out the type of cancer present in the patient’s body. With this unique quality CEA tests demand and market will be in huge demand and this market will be highly lucrative.
Carcinoembryonic Antigen (CEA) market for North America is one of the biggest markets in the globe the main reason behind this is the Cancer rate in the North American countries. Cancer usually develops in older people 86% of all cancers in the United States are diagnosed in people 50 years of age or older.
Typical behaviors also increase the risk of being diagnosed by cancer, these include eating unhealthy diet, heavy smocking or not being physically active. According to cancer facts and figures 2016 US, in a life time the probable risk of developing cancer in men in 42%, one in two men and for women it is 38% that is one in three women. It is estimated that 16,85,210 new cancer case are found in the US every year out of which 5,95,690 have ended up in deaths. With the rate of growth cancer is facing it can easily be estimated that the amount of test taken to diagnose cancer will increase, out of which one test is Carcinoembryonic Antigen (CEA) test. Hence this market will gain huge demand and is expect to grow at a very high growth rate.
Browse Full Report Details at https://www.marketresearchfuture.com/reports/carcinoembryonic-antigen-market
Europe is the second largest market for Carcinoembryonic Antigen (CEA). This is also because the high growth rate of cancer in Europe. Most cancers are related to lifestyle, behavioral or environmental exposures. The term environmental is used by cancer experts because it refers to everything outside the body that is being interacted with humans. in this sense, the environment is not limited to the biophysical environment(pollution, air, sunlight etc) it also includes lifestyle behavior factors, common behavior factors that lead to cancer is tobacco, diet, obesity, radiation, stress and environmental pollutions. As per FACE in 2009 all European countries had 2,333,407 number of new cancers cases and is expect to grow to 2,660,561 in 2020 with a percentage increase of 14.0. with this growth rate the market for Carcinoembryonic Antigen (CEA) tests will increase and it will face tremendous growth in the coming future.
The reports also covers brief analysis of Geographical Region includes:
- North America
- Latin America
- Western Europe
Rest of Western Europe
- South Korea
- Rest of Asia
- Pacific Countries
The Middle East& Africa
The report for Global Carcinoembryonic Antigen (CEA) Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
+1 646 845 9312